Tachibana Taro

タチバナタロウ | Tachibana Taro

Affiliation and department：
Job title： Professor
Other affiliations (1)：

Homepage URL (1)： https://www.omu.ac.jp/eng/ddb/

Research field (1)： Cell biology

Research keywords (2)：抗体医薬品 , モノクローナル抗体

Research theme for competitive and other funds (19)：

2024 - 2027 Development of novel tumor marker and targeting-antibody against pancreatic ductal adenocarcinoma
2024 - 2027 アスタチンー211標識ヒト・キメラCD82抗体による難治白血病に対する治療法の開発
2022 - 2025 生活習慣病モデルメダカを用いた歯周病合併症の予防抑制効果を示す食品由来物質の探索
2020 - 2023 特異的抗体を用いた転移性がん細胞表面分子の同定と創薬応用
2019 - 2023 Identification of novel cell surface antigens for cancer stem cells using single-cell technology

Show all

Papers (309)：

Saki Egashira, Taro Tachibana, Mako Nakamura, Yasuyuki Ohkawa, Akihito Harada. Monoclonal Antibody Rat 2F11 and Rabbit A3 Against Anti-H2b3b. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2024. 43. 2. 81-82
Egashira S, Tachibana T, Nakamura M, Ohkawa Y, Harada A. Production of a Monoclonal Antibody for Histone H2b Isoform H2b3b. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2024
Minami S, Kotaki T, Sakai Y, Okamura S, Torii S, Ono C, Motooka D, Hamajima R, Nouda R, Nurdin JA, et al. Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage. Microbiology spectrum. 2024. e0285923
Kosuke Tomimatsu, Takeru Fujii, Ryoma Bise, Kazufumi Hosoda, Yosuke Taniguchi, Hiroshi Ochiai, Hiroaki Ohishi, Kanta Ando, Ryoma Minami, Tachibana Taro, et al. Precise immunofluorescence canceling for highly multiplexed imaging capturing specific cell state. 2023
Okagawa T, Konnai S, Goto S, Sajiki Y, Ganbaatar O, Watari K, Nakamura H, Wang CX, Tachibana T, Kato Y, et al. Development of a high-affinity anti-bovine PD-1 rabbit-bovine chimeric antibody using an efficient selection and large production system. Veterinary research. 2023. 54. 1. 82

ｍore...

MISC (29)：

Fukui Saki, Terao Kazuma, Koma Daisuke, Ohmoto Takashi, Tachibana Taro, Azuma Masayuki. 1P-171 Effect of intercellular metabolism mutation on power in glucose fuel cell using Escherichia coli. 2015. 67. 131-131
Hashimoto Kazutoshi, Zhang Kai, Tachibana Taro, Azuma Masayuki. 1P-170 Characteristics of xylose fuel cell using Escherichia coli as a catalyst. 2015. 67. 131-131
Onishi Masaya, Matsumoto Azusa, Nerome Shinsuke, Tachibana Taro, Azuma Masayuki. 3P-055 Analyses of Saccharomyces cerevisiae mutants releasing a biosurfactant from cells and its biosurfactant. 2015. 67. 284-284
Liu Tao, Nobeshima Hirobumi, Tachibana Taro, Azuma Masayuki. 3P-155 Characteristics of poly-glutaminc acid produced by Bacillus sp. isolated from nature and its application. 2015. 67. 309-309
立花太郎. 抗体医薬品産業の現状と展望. 日本試薬協会試薬会誌. 2015. 47. 13-15

ｍore...

Education (3)：

Professional career (1)：

Work history (8)：

2022/04 - 現在 Osaka Metropolitan University Graduate School of Engineering Division of Science and Engineering for Materials, Chemistry and Biology Professor
2022/02 - 現在パンクセラピー株式会社代表取締役
2017/10/01 - 現在 Osaka City University Graduate School of Engineering
2010/02 - 現在株式会社細胞工学研究所代表取締役
2007/04/01 - 2017/09/30 Osaka City University Graduate School of Engineering

Show all

Awards (2)：

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page